Amplification options for patients with mixed hearing loss
| Autor: | Ad F. M. Snik, Emmanuel A. M. Mylanus, Jef J. S. Mulder, Joost W. Zwartenkot |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
medicine.medical_specialty
Hearing loss Other Research Donders Center for Medical Neuroscience [Radboudumc 0] Audiology Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12] Loudness Bone conduction Hearing Aids medicine otorhinolaryngologic diseases Humans Cochlea Hearing Loss Mixed Conductive-Sensorineural business.industry Dynamic range Treatment options medicine.disease Sensory Systems Ossicular Prosthesis medicine.anatomical_structure Treatment Outcome Otorhinolaryngology Acoustic Stimulation Middle ear Sensorineural hearing loss Neurology (clinical) medicine.symptom business Bone Conduction |
| Zdroj: | Otology & Neurotology, 35, 221-6 Otology & Neurotology, 35, 2, pp. 221-6 |
| ISSN: | 1531-7129 |
| Popis: | Item does not contain fulltext OBJECTIVES: To compare amplification options for patients with mixed hearing loss. Devices tested include percutaneous and transcutaneous bone conductors (BCDs) and middle ear implants with their actuator directly coupled to the cochlea. SETTING: Tertiary academic medical center. METHOD AND PARTICIPANTS: Maximum output was studied with simulators. As simulators are lacking for the middle ear implants (the Vibrant Soundbridge [VSB] and the Cochlear's Direct Acoustic Cochlear Stimulator [Codacs]), the maximum output had to be measured in patients (4 and 5 patients, respectively). MAIN OUTCOME MEASURE: The maximum output averaged at 0.5, 1, and 2 kHz was the main outcome measure, which was expressed in dB HL, using appropriate transformation tables. RESULTS: The maximum output was the highest for the Codacs device and was above the patients' uncomfortable loudness levels. The maximum output of the VSB varied between 65 and 85 dB HL, and that of percutaneous BCD varied between 68 and 80 dB HL depending on the type of device. The transcutaneous BCD, the Sophono device, had the lowest output. CONCLUSION: Only with the Codacs device can the complete dynamic range be used. The maximum output of the VSB is lower and variable owing to the coupling to the cochlea. For patients with a sensorineural hearing loss component up to 50 dB HL, a percutaneous BCD forms a good treatment option that is completely independent of the middle ear status. The transcutaneous Sophono BCD is suitable for patients with a (sub-)normal sensorineural hearing loss component of 20 dB or less. 01 februari 2014 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|